Ask AI
ART Choice in Comorbidities

CE / CME

ART Choice in Treatment-Experienced People With HIV and Comorbidities

Pharmacists: 0.50 contact hour (0.05 CEUs)

Physicians: Maximum of 0.50 AMA PRA Category 1 Credit

Released: July 14, 2025

Expiration: July 13, 2026

Pretest

Progress
1 2 3
Course Completed
Please answer the questions below.
1.

You are considering using fostemsavir in a new regimen for a person with HIV who is highly treatment experienced, has cardiovascular disease and elevated inflammatory markers, and has a CD4+ cell count of 55 cells/mm³. Based on the BRIGHTE study, which of the following can you expect over the next year if virologic suppression is achieved?